Wade R Smith Selected Research

Wade R Smith Research Topics

Disease

12	Wounds and Injuries (Trauma) 07/2013 - 12/2006
5	Infections 12/2011 - 01/2005
5	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2010 - 06/2006
4	Craniocerebral Trauma (Head Injury) 02/2010 - 06/2006
3	Hemorrhage 02/2012 - 01/2007
3	Multiple Trauma (Multiple Injuries) 07/2010 - 10/2006
3	Open Fractures (Compound Fracture) 07/2010 - 01/2008
3	Neuroinflammatory Diseases 01/2009 - 06/2006
2	Bone Fractures (Bone Fracture) 09/2013 - 05/2006
2	Pain (Aches) 08/2012 - 12/2006
2	Femoral Fractures (Femoral Fracture) 12/2010 - 05/2006
2	Compartment Syndromes 11/2010 - 07/2010
2	Sepsis (Septicemia) 01/2009 - 04/2008
1	Distal Femoral Fractures 01/2016
1	Osteoarthritis 08/2012
1	Osteoporosis 08/2012
1	Congenital Abnormalities (Deformity) 08/2012
1	Tibial Fractures (Fracture, Tibial) 12/2011
1	Body Weight (Weight, Body) 07/2011
1	Shock 04/2011
1	Paralysis (Palsy) 10/2010
1	Ischemia 08/2010
1	Renal Insufficiency (Renal Failure) 08/2010
1	Vascular System Injuries 08/2010
1	Soft Tissue Injuries (Soft Tissue Injury) 07/2010
1	Wound Infection (Wound Infections) 06/2010
1	Surgical Wound Infection 04/2010
1	Exsanguination 01/2009
1	Brain Edema (Cerebral Edema) 01/2009
1	Osteomyelitis 04/2008
1	Pelvic Infection 04/2008
1	Arthritis (Polyarthritis) 01/2008
1	Pseudarthrosis (Pseudoarthrosis) 01/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2008
1	Venous Thromboembolism 01/2007
1	Postoperative Pain 12/2006
1	Inflammation (Inflammations) 07/2006
1	Distal Humeral Fractures 01/2005
1	Heterotopic Ossification (Ectopic Ossification) 01/2005
1	Ulnar Neuropathies (Ulnar Neuropathy) 01/2005

Drug/Important Bio-Agent (IBA)

4	Complement System Proteins (Complement)IBA 01/2009 - 06/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2010 - 04/2008
1	tributyl phosphate (TBP)IBA 07/2013
1	IS 35IBA 07/2011
1	Reactive Nitrogen SpeciesIBA 01/2009
1	Peptide Hydrolases (Proteases)FDA Link 01/2009
1	Complement C5a (Complement 5a)IBA 01/2009
1	CytokinesIBA 01/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2009
1	ChemokinesIBA 01/2009
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2008
1	DNA Transposable Elements (Element, IS)IBA 12/2007
1	Biological ProductsIBA 12/2007
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2007
1	Dalteparin (Dalteparin Sodium)FDA Link 01/2007
1	Narcotics (Narcotic Analgesics)IBA 12/2006
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 12/2006
1	Local AnestheticsIBA 12/2006
1	Proteins (Proteins, Gene)FDA Link 10/2006
1	Complement C3-C5 Convertases (C3 Convertase)IBA 06/2006

Therapy/Procedure

4	Surgical Amputation (Amputations) 12/2011 - 03/2008
3	Fracture Fixation 04/2010 - 05/2009
2	Debridement 12/2011 - 04/2008
2	Blood Transfusion (Blood Transfusions) 04/2011 - 01/2009
2	Arthroplasty 12/2010 - 01/2005
2	External Fixators 07/2010 - 01/2008
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2016
1	Bone Transplantation (Bone Grafting) 09/2013
1	Analgesia 08/2012
1	Advanced Trauma Life Support Care 03/2012
1	Resuscitation 02/2012
1	Negative-Pressure Wound Therapy 12/2011
1	Therapeutics 12/2011
1	Length of Stay 12/2011
1	Traction 11/2010
1	Decompression 10/2010
1	Critical Care (Surgical Intensive Care) 08/2010
1	Vascular Surgical Procedures 08/2010
1	Hemipelvectomy 04/2008
1	Operative Time 04/2008
1	Conservative Treatment 04/2008
1	Terminal Care (Care, Terminal) 04/2008
1	Patient Positioning 01/2008
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2008
1	Laparotomy 04/2007
1	Therapeutic Embolization 04/2007
1	Nutritional Support (Artificial Feeding) 10/2006
1	Intramedullary Fracture Fixation 05/2006
1	Osteotomy 01/2005